• FAQs
  • Glossary
Close

FAQs

What is gene and cell therapy?
What are ATMPs, and where do they fit into gene and cell therapy?
Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

See full Glossary

The EU CAR-T Handbook

The European Society for Blood and Marrow Transplantation (EBMT), European Hematology Association (EHA), and the GoCART Coalition has released the second edition of the EU CAR-T Handbook. This updated edition is a comprehensive, open-access resource covering the latest developments in CAR-T cell therapies.

 

The first edition of the handbook is available here.

 

EU CAR-T handbook cover

The EU CAR-T Handbook

Go to resource

Back to Research Pathways

Back to top
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts